Speaker

Sridevi Nagarajan

Sridevi Nagarajan

R&D Executive Leader

Cambridge, United Kingdom

Actions

Transformational R&D Leader delivering validated ROI through AI-enabled digital modernization, regulatory systems innovation, regulatory strategy development, and scaled global operating models. Proven expertise in architecting enterprise-wide frameworks adopted globally across regulatory affairs, CMC, clinical development, quality, and safety. Recognized as a thought leader on regulatory strategy and technology. Track record translating business strategy into operational capabilities that accelerate product approvals and optimize R&D portfolio performance

Area of Expertise

  • Business & Management
  • Health & Medical
  • Information & Communications Technology
  • Physical & Life Sciences

(D2S3) Session 3: Navigating the AI Frontier in MedTech: From SaMD to AI-Driven Drug Development

2:00 – 3:30 PM Session 3: Navigating the AI Frontier in MedTech: From SaMD to AI-Driven Drug Development

Session Chair: Sridevi Nagarajan, Founder & Director, AyusArogya Ltd.; DIA Communities Chair for AI in Healthcare

Session Focus: The global MedTech environment for medical AI has reached a decisive turning point. Topics addressed include SaMD classification under the EU AI Act and FDA guidance; AI applications in drug development and MedTech innovation; validation and lifecycle control for adaptive algorithms; cybersecurity obligations; post-market surveillance; and a multi-jurisdictional regulatory strategy spanning the FDA, EMA, MHRA, and CDSCO.

2:00 – 2:15 PM S3.T1: The Regulatory Landscape in 2026 [15 min]
Sridevi Nagarajan (Session Chair)

2:15 – 2:30 PM S3.T2: AI in Drug Development & MedTech Innovation [15 min]
Adarsh Srivastava, Head of IVD Data Insights – Data, Analytics & Research, Roche, India

2:30 – 2:45 PM S3.T3: Validation, Cybersecurity & Lifecycle Control [15 min]
Jaydeep Ruparelia, Founder and CEO, Infopercept
2:45 – 3:30 PM S3.T4: Panel Discussion: Future of AI in MedTech [45 min]
Moderator: Sridevi Nagarajan
Panelists: Speakers with the additional presence of:
3. Aseem Sahu, Deputy Drug Controller (DDC), Medical Device Division, CDSCO (HQ), India
4. Rohit Philip, Senior Program Consultant, KMTC
5. MiRa Jacobs, PhD, Head of Digital Health, MHRA, UK – Virtual
6. Vivek Ahuja, MD, EVP – Global Delivery Excellence, Strategy & Growth, Eversana

Sridevi Nagarajan

R&D Executive Leader

Cambridge, United Kingdom

Actions

Please note that Sessionize is not responsible for the accuracy or validity of the data provided by speakers. If you suspect this profile to be fake or spam, please let us know.

Jump to top